From Reuters.

Novo Nordisk’s shares tumbled nearly 20% as the Danish obesity drug giant warned it would face ‘unprecedented’ price pressures in 2026.

#News #Reuters #Newsfeed #business #weightloss

Read the story here: https://reut.rs/46tdHzq

👉 Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en